Q91WD0
Gene name |
Gpr108 (Lustr2) |
Protein name |
Protein GPR108 |
Names |
Lung seven transmembrane receptor 2 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:78308 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q91WD0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q91WD0-F1 | Predicted | AlphaFoldDB |
28 variants for Q91WD0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3389441612 | 2 | A>V | No | EVA | |
| rs3389386472 | 10 | S>R | No | EVA | |
| rs3389478110 | 12 | E>* | No | EVA | |
| rs3389468234 | 13 | S>R | No | EVA | |
| rs226301519 | 80 | L>F | No | EVA | |
| rs3389478031 | 104 | H>Y | No | EVA | |
| rs3389476917 | 126 | L>M | No | EVA | |
| rs108333746 | 150 | T>S | No | EVA | |
| rs3407887726 | 174 | T>SL* | No | EVA | |
| rs3389441628 | 179 | V>I | No | EVA | |
| rs3389468897 | 183 | Q>H | No | EVA | |
| rs213470309 | 197 | E>G | No | EVA | |
| rs3389468940 | 199 | R>G | No | EVA | |
| rs3389423594 | 210 | D>E | No | EVA | |
| rs244352926 | 218 | Q>L | No | EVA | |
| rs52767493 | 246 | Y>C | No | EVA | |
| rs52767492 | 250 | F>L | No | EVA | |
| rs52767491 | 254 | H>D | No | EVA | |
| rs258390509 | 254 | H>R | No | EVA | |
| rs52767490 | 256 | S>C | No | EVA | |
| rs236677283 | 295 | A>V | No | EVA | |
| rs3389466770 | 312 | T>I | No | EVA | |
| rs3389491165 | 347 | G>C | No | EVA | |
| rs3389476955 | 363 | L>V | No | EVA | |
| rs3389423545 | 371 | T>S | No | EVA | |
| rs3389478094 | 404 | A>D | No | EVA | |
| rs3389386505 | 444 | V>I | No | EVA | |
| rs3389454239 | 500 | Q>* | No | EVA |
No associated diseases with Q91WD0
No regional properties for Q91WD0
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q91WD0 | |||
Functions
6 GO annotations of cellular component
| Name | Definition |
|---|---|
| cis-Golgi network membrane | The lipid bilayer surrounding any of the compartments that make up the cis-Golgi network. |
| Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
| Golgi membrane | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| trans-Golgi network | The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of toll-like receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor signaling pathway. |
| regulation of immune response | Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAVSERRGLS | GESPTQCRWG | YLSLLVLTLS | GCSGRIHRLT | LTGEKRADIQ | LNSFGFYTNG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| SLEVELSLLR | LSLQETEKKL | PKVGFSLSRV | RSGSVRSYSR | RNSHECPLDR | NSSNFLVLFL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| INIKDLQVQV | RKYGEQKLFI | SPGLLPEAPT | QSGPPKPDPA | GTPKDNHVIH | PSPTEMSAVK |
| 190 | 200 | 210 | 220 | 230 | 240 |
| ENQTAPQVSG | DKTTPGEHRH | SSERQPPTQD | PSGKEKDQVL | GLGHLNDSYN | FSFHIVISSR |
| 250 | 260 | 270 | 280 | 290 | 300 |
| AEEGQYSLNF | HNCHNSIPGQ | EQPFDLTVMI | REKNPEGFLS | AAEIPLFKLY | LIMSACFLAA |
| 310 | 320 | 330 | 340 | 350 | 360 |
| DIFWVSVLCK | NTYSVFKIHW | LMAALAFTKS | VSLLFHSINY | YFINSQGHPI | EGLAVMHYIT |
| 370 | 380 | 390 | 400 | 410 | 420 |
| HLLKGALLFI | TIALIGSGWA | FVKYMLSDKE | KKIFGIVIPL | QVLANVAYIV | IESREEGASD |
| 430 | 440 | 450 | 460 | 470 | 480 |
| YGLWKEILFL | VDLICCGAIL | FPVVWSIRHL | QDASGTDGKV | AVNLARLKLF | RHYYVMVICY |
| 490 | 500 | 510 | 520 | 530 | 540 |
| IYFTRIIAIL | LQVAVPFQWQ | WLYQLLVESS | TLAFFVLTGY | KFQPAGDNPY | LQLPQEDEED |
| 550 | 560 | ||||
| VQMEQVMTDS | GFREGLSKVN | KTASGRELL |